Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Boston, MA.
Sector:
Health Services
Industry:
Medical Or Nursing Services
Employees:
1
Frequently Asked Questions
What is Market Cap of Finch Therapeutics Group Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Finch Therapeutics Group Inc market cap is $20.39M.
What is the 52-week high for Finch Therapeutics Group Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Finch Therapeutics Group Inc 52 week high is $15.85 as of September 08, 2025.
What is the 52-week low for Finch Therapeutics Group Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Finch Therapeutics Group Inc 52 week low is $10.15 as of September 08, 2025.
What is Finch Therapeutics Group Inc stock price today?
Finch Therapeutics Group Inc stock price today is $12.70.
What was Finch Therapeutics Group Inc stock price yesterday?
Finch Therapeutics Group Inc stock price yesterday was $12.60.
What is the PE ratio of Finch Therapeutics Group Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Finch Therapeutics Group Inc’s P/E ratio is -1.44.
What is the Price-to-Book ratio of Finch Therapeutics Group Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Finch Therapeutics Group Inc P/B ratio is 1.4342.
What is the 50-day moving average of Finch Therapeutics Group Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Finch Therapeutics Group Inc 50-day moving average is $12.65.
How many employess does Finch Therapeutics Group Inc has?